Joyce Kuntze

2.1k total citations
19 papers, 1.5k citations indexed

About

Joyce Kuntze is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Joyce Kuntze has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Joyce Kuntze's work include Growth Hormone and Insulin-like Growth Factors (10 papers), Sexual Differentiation and Disorders (9 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (5 papers). Joyce Kuntze is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (10 papers), Sexual Differentiation and Disorders (9 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (5 papers). Joyce Kuntze collaborates with scholars based in United States, Brazil and France. Joyce Kuntze's co-authors include Steven D. Chernausek, James W. Frane, Kenneth M. Attie, Ann J. Johanson, Barbara M. Lippe, Joyce Baptista, Paul Saenger, Philippe Backeljauw, Richard Ν. Fine and Sandra L. Blethen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Kidney International.

In The Last Decade

Joyce Kuntze

19 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joyce Kuntze United States 18 987 678 598 331 223 19 1.5k
MB Ranke Germany 22 861 0.9× 601 0.9× 554 0.9× 291 0.9× 212 1.0× 62 1.4k
K W Kastrup Denmark 18 878 0.9× 349 0.5× 482 0.8× 261 0.8× 159 0.7× 47 1.4k
Gerdine A. Kamp Netherlands 18 792 0.8× 430 0.6× 283 0.5× 343 1.0× 155 0.7× 34 1.1k
Donatella Capalbo Italy 25 1.2k 1.2× 338 0.5× 302 0.5× 244 0.7× 120 0.5× 72 1.6k
M O Savage United Kingdom 23 1.2k 1.2× 501 0.7× 557 0.9× 239 0.7× 249 1.1× 67 1.7k
Seizo Suwa Japan 19 632 0.6× 740 1.1× 415 0.7× 206 0.6× 42 0.2× 80 1.4k
Juliane Léger France 15 564 0.6× 320 0.5× 357 0.6× 315 1.0× 35 0.2× 26 1.1k
M. Vandeweghe Belgium 12 940 1.0× 277 0.4× 178 0.3× 180 0.5× 128 0.6× 30 1.1k
C. P. Schwarze Germany 15 325 0.3× 234 0.3× 249 0.4× 173 0.5× 111 0.5× 26 671
Jose Bernardo Quintos United States 16 683 0.7× 430 0.6× 357 0.6× 193 0.6× 106 0.5× 59 1.2k

Countries citing papers authored by Joyce Kuntze

Since Specialization
Citations

This map shows the geographic impact of Joyce Kuntze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce Kuntze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce Kuntze more than expected).

Fields of papers citing papers by Joyce Kuntze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce Kuntze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce Kuntze. The network helps show where Joyce Kuntze may publish in the future.

Co-authorship network of co-authors of Joyce Kuntze

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce Kuntze. A scholar is included among the top collaborators of Joyce Kuntze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce Kuntze. Joyce Kuntze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Blethen, Sandra L., et al.. (2014). Managing the Child with Severe Primary Insulin-Like Growth Factor-1 Deficiency (IGFD): IGFD Diagnosis and Management. Drugs in R&D. 14(1). 25–29. 17 indexed citations
2.
Backeljauw, Philippe, Joyce Kuntze, James W. Frane, Ali S. Çalıkoğlu, & Steven D. Chernausek. (2013). Adult and Near-Adult Height in Patients with Severe Insulin-Like Growth Factor-I Deficiency after Long-Term Therapy with Recombinant Human Insulin-Like Growth Factor-I. Hormone Research in Paediatrics. 80(1). 47–56. 34 indexed citations
3.
Chernausek, Steven D., et al.. (2006). Long-Term Treatment with Recombinant Insulin-Like Growth Factor (IGF)-I in Children with Severe IGF-I Deficiency due to Growth Hormone Insensitivity. The Journal of Clinical Endocrinology & Metabolism. 92(3). 902–910. 170 indexed citations
4.
Kemp, Stephen F., Joyce Kuntze, Kenneth M. Attie, et al.. (2005). Efficacy and Safety Results of Long-Term Growth Hormone Treatment of Idiopathic Short Stature. The Journal of Clinical Endocrinology & Metabolism. 90(9). 5247–5253. 92 indexed citations
5.
Hoffman, Andrew R., Joyce Kuntze, Joyce Baptista, et al.. (2004). Growth Hormone (GH) Replacement Therapy in Adult-Onset GH Deficiency: Effects on Body Composition in Men and Women in a Double-Blind, Randomized, Placebo-Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 89(5). 2048–2056. 135 indexed citations
6.
Quattrin, Teresa, et al.. (2001). Improvement of HbA1c Without Increased Hypoglycemia in Adolescents and Young Adults with Type 1 Diabetes Mellitus Treated with Recombinant Human Insulin-like Growth Factor-I and Insulin. Journal of Pediatric Endocrinology and Metabolism. 14(3). 267–77. 21 indexed citations
7.
Fine, Richard Ν., et al.. (2000). The impact of recombinant human growth hormone treatment during chronic renal insufficiency on renal transplant recipients. The Journal of Pediatrics. 136(3). 376–382. 31 indexed citations
8.
Thrailkill, Kathryn M., Teresa Quattrin, L. Baker, et al.. (1999). Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group.. Diabetes Care. 22(4). 585–592. 72 indexed citations
9.
Rosenfeld, Ron G., Kenneth M. Attie, James W. Frane, et al.. (1998). Growth hormone therapy of Turner's syndrome: Beneficial effect on adult height. The Journal of Pediatrics. 132(2). 319–324. 194 indexed citations
10.
Blethen, Sandra L., Joyce Baptista, Joyce Kuntze, et al.. (1997). Adult Height in Growth Hormone (GH)-Deficient Children Treated with Biosynthetic GH. The Journal of Clinical Endocrinology & Metabolism. 82(2). 418–420. 176 indexed citations
11.
Fine, Richard Ν., et al.. (1996). Growth after discontinuation of recombinant human growth hormone therapy in children with chronic renal insufficiency. The Journal of Pediatrics. 129(6). 883–891. 18 indexed citations
12.
Fine, Richard Ν., et al.. (1996). Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone. Kidney International. 49(3). 781–785. 81 indexed citations
13.
Fine, Richard Ν., et al.. (1995). Recombinant human growth hormone in infants and young children with chronic renal insufficiency. Pediatric Nephrology. 9(4). 451–457. 40 indexed citations
14.
Hopwood, Nancy J., Raymond L. Hintz, Joseph M. Gertner, et al.. (1993). Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy. The Journal of Pediatrics. 123(2). 215–222. 108 indexed citations
15.
Rosenfeld, Ron G., James L. France, Kenneth M. Attie, et al.. (1992). Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome. The Journal of Pediatrics. 121(1). 49–55. 134 indexed citations
16.
Rosenfeld, Ron G., Kenneth M. Attie, James W. Frane, et al.. (1992). Growth hormone therapy in Turner's syndrome: An update on final height. 81(383). 3–6. 7 indexed citations
17.
Rosenfeld, Ron G., Raymond L. Hintz, Ann J. Johanson, et al.. (1988). Three-year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome. The Journal of Pediatrics. 113(2). 393–400. 91 indexed citations
18.
Delamater, Alan M., Jeanne Bubb, Steven M. Kurtz, et al.. (1988). Physiologic Responses to Acute Psychological Stress in Adolescents with Type 1 Diabetes Mellitus. Journal of Pediatric Psychology. 13(1). 69–86. 21 indexed citations
19.
Rosenfeld, Ron G., Raymond L. Hintz, A Johanson, et al.. (1986). Methionyl human growth hormone and oxandrolone in Turner syndrome: Preliminary results of a prospective randomized trial. The Journal of Pediatrics. 109(6). 936–943. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by MB Ranke Breakdown of academic impact, for papers by K W Kastrup Breakdown of academic impact, for papers by Gerdine A. Kamp Breakdown of academic impact, for papers by Donatella Capalbo Breakdown of academic impact, for papers by M O Savage Breakdown of academic impact, for papers by Seizo Suwa Breakdown of academic impact, for papers by Juliane Léger Breakdown of academic impact, for papers by M. Vandeweghe Breakdown of academic impact, for papers by C. P. Schwarze Breakdown of academic impact, for papers by Jose Bernardo Quintos
Rankless by CCL
2026